Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cronos Group Inc T.CRON

Alternate Symbol(s):  CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and... see more

Bullboard (TSX:CRON)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 Next
Post by Wrywisdomon Aug 10, 2022 3:26pm

Incredible Value. ENTG at about 25% of One Years Revenue

.with revenues now demonstrating an upward Trajectory amd likely attaining profitability within a couple of quarters. May reportage for example indicates record first quarter 2022 results:   ...more  
148
Post by Betteryear2on Aug 07, 2022 5:02pm

Don't Rule Out A Bull Market (Podcast Transcript)

Happy to have Alan Brochstein back! Thoughts on the recent rally (less about Bulls buying than Bears covering), political doubts and overall optimism. Valuations are low, but there's good news ...more  
202
Discussion
Post by Wrywisdomon Jul 15, 2022 1:18pm

ENTG Extends Primary Credit Facility with BMO/Others 2+Years

For those not aware, Entourage has extended and improved it's primary credit facility with Bank of Montreal for two more years, furthering it's relationship with one of Canada's most ...more  
116
Post by JayDesturaon Jun 03, 2022 3:49am

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of FSD ...more  
161
Post by AwareInvestoron May 10, 2022 7:54am

Cronos Group Sees Revenues Stay Flat In First Quarter Versus

Cronos Group this morning posted its first quarter financial results for 2022. Surprisingly, the company appears to be becoming a bit of a comeback story, with its performance overall improving over ...more  
384
Post by JayDesturaon Apr 15, 2022 8:41am

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings ...more  
152
Post by cannabiscon Apr 14, 2022 6:29pm

Investor Alert ! 🚨 Cash Positive cannabis operations !

Investors need to stop drinking the Kool-Aid and continuing to fund mis-guided companies with hard earned investor money, that has already been lost a long time ago. With absolutely no guidance to ...more  
221
Post by Ghostinthedarkon Apr 11, 2022 12:06pm

Hexo trade sideways at .64 cents

Another play could be Cron...headed back down to 3.78, after a pop to over $5.00. Love those rear entries when the stock is at the bottom. AS for HeXO, stock is already there...Cannot believe it will ...more  
219
Post by JayDesturaon Apr 09, 2022 12:05am

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ...more  
174
Post by JayDesturaon Apr 07, 2022 1:24am

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to ...more  
154
Prev 1 2 3 4 5 6 7 8 9 10 11 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities